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Abstract
Background: Several studies have investigated the effect of known adult body mass
index (BMI) associated single nucleotide polymorphisms (SNPs) on BMI in childhood.
There has been no genome-wide association study (GWAS) of BMI trajectories over
childhood.
Methods: We conducted a GWAS meta-analysis of BMI trajectories from 1 to 17 years of
age in 9377 children (77 967 measurements) from the Avon Longitudinal Study of
Parents and Children (ALSPAC) and the Western Australian Pregnancy Cohort (Raine)
Study. Genome-wide significant loci were examined in a further 3918 individuals (48 530
measurements) from Northern Finland. Linear mixed effects models with smoothing
splines were used in each cohort for longitudinal modelling of BMI.
VC The Author 2015; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 700
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
International Journal of Epidemiology, 2015, 700–712
doi: 10.1093/ije/dyv077











Results: A novel SNP, downstream from the FAM120AOS gene on chromosome 9, was
detected in the meta-analysis of ALSPAC and Raine. This association was driven by a dif-
ference in BMI at 8 years (T allele of rs944990 increased BMI; PSNP¼1.52108), with a
modest association with change in BMI over time (PWald(Change)¼0.006). Three known
adult BMI-associated loci (FTO, MC4R and ADCY3) and one childhood obesity locus
(OLFM4) reached genome-wide significance (PWald<1.13 108) with BMI at 8 years
and/or change over time.
Conclusions: This GWAS of BMI trajectories over childhood identified a novel locus that
warrants further investigation. We also observed genome-wide significance with previously
established obesity loci, making the novel observation that these loci affected both the level
and the rate of change in BMI. We have demonstrated that the use of repeated measures
data can increase power to allow detection of genetic loci with smaller sample sizes.
Key words: Body mass index, genome-wide association study, trajectory, childhood, ALSPAC, Raine
Introduction
Obesity, defined by high body mass index (BMI), is a com-
plex condition associated with an increased risk of many
chronic diseases.1 Evidence suggests that the adverse health
consequences of obesity begin in early life.2–4 BMI in
adults primarily reflects weight independent of height;
however, changes in BMI throughout childhood are influ-
enced by changes in both height and weight.
Choh et al.5 estimated that the narrow-sense heritability of
BMI over infancy, childhood and adolescence ranges from
47% to 76%, with similar estimates reported in adults.6,7
Genome-wide association studies (GWAS) have identified
and replicated 34 adult BMI-associated loci (P-values
< 5 108 from discovery and replication meta-analysis)8–10
that explain approximately 1.5% of the variance in adult
BMI. Several studies have investigated the association be-
tween these adult BMI SNPs and childhood BMI, including
BMI trajectories.11–15 These publications have shown that
SNPs associated with adult BMI are not associated with
birthweight or length, but have effects that begin from early
infancy and strengthen throughout childhood and adoles-
cence. The effects of some variants appear to change over
time, for example the A allele at the FTO rs9939609 SNP is
associated with a lower BMI in infancy but a higher BMI
from 5.5 years onwards.16 In contrast, the ADCY3
rs11676272 SNP has been shown to have consistent effects
across ages.17 A GWAS investigating childhood obesity (i.e.
BMI> 95th percentile) in populations of European descent18
identified two novel loci, one near the olfactomedin 4
(OLFM4) gene and the other in the homeobox B5 (HOXB5)
gene. The results of these studies suggest that the expression
of genetic variants may change across the life course.
In a recent review of obesity genetics, Day and Loos
highlight the importance of conducting GWAS in children
and adolescents to identify loci that may have effects early
in life rather than adulthood.19 Therefore, the aim of the
current study was to investigate the genetic basis of BMI
and BMI trajectories across childhood and adolescence.
Key Messages
• We performed a genome-wide association study of body mass index trajectories over childhood and adolescence
using repeated measures data from two large cohort studies.
• A novel association between body mass index at 8 years of age and single nucleotide polymorphisms near the
FAM120AOS gene on chromosome 9 was identified. The top SNP in this region begins to have an observable effect
on BMI around 2 years of age, and the effect appears to be driven by changes in weight rather than height. This asso-
ciation warrants further investigation.
• Novel associations between several known adult body mass index-associated loci and body mass index at 8 years of
age and/or change in body mass index over childhood were observed. In addition, a known childhood obesity-
associated locus was associated with body mass index at 8 years of age.
• Through the use of repeated measures data, genetic associations can be detected with smaller sample sizes.
• Our results highlight that the genetic determinants of susceptibility to obesity in adulthood begin acting in early life
and develop over the life course.












ALSPAC. The Avon Longitudinal Study of Parents and
Children (ALSPAC) is a prospective cohort. Details on the
BMI measurements are provided in Supplementary material
(available as Supplementary data at IJE online) and the full
study methodology is published elsewhere20 [www.bristol.ac.
uk/alspac]. The study website contains details of all the data
that are available through a fully searchable data dictionary
[http://www.bris.ac.uk/alspac/researchers/data-access/data-dic
tionary]. A subset of 7916 individuals (69 297 observations)
were included in this study based on the following criteria:
1 parent of European descent, live singleton birth, unrelated
to anyone in the sample, no major congenital anomalies, gen-
otype data, and 1 measure of BMI between ages 1 and 17
years. Ethical approval for the study was obtained from the
ALSPAC Law and Ethics Committee and the local research
ethics committees.
Raine. The Western Australian Pregnancy Cohort (Raine)
Study21–23 is a prospective pregnancy cohort [http://
www.rainestudy.org.au/] (specific methods in
Supplementary material, available as Supplementary
data at IJE online). A subset of 1461 individuals (8670
observations) was included in this study, using the same
criteria as in the ALSPAC cohort. The study was
conducted with institutional ethics approval from the
King Edward Memorial Hospital and Princess Margaret
Hospital for Children human research ethics committees.
Genotyping
Imputed genotypic data used in both cohorts has been
described previously.24,25 Briefly, genotype data in both
cohorts were cleaned using standard thresholds (HWE
P> 5.7 107, call rate >95% and minor allele frequency
>1%). Imputation for chromosomes 1 to 22 was per-
formed with the MACH software26 using the CEU samples
from HapMap Phase 2 (Build 36, release 22) as a reference
panel.
Within-study GWAS analysis and quality control
BMI was skewed, so a natural log transformation was applied
before analysis. A semi-parametric linear mixed model was fit-
ted to the BMI measures with mean centred age (centred at
age 8); smoothing splines, with knot points at two, eight and
12 years and a cubic slope for each spline, were used to pro-
duce a smooth growth curve estimate.27 A continuous autore-
gressive of order 1 correlation structure was assumed. Full
details of the statistical methodology are in Supplementary
material, available as Supplementary data at IJE online.
The fixed effects in the ALSPAC model included a
binary indicator of measurement source (questionnaire vs
clinic or health visitor measurement) to allow for differen-
tial measurement error. The fixed effects in the Raine
model included the first five principal components for pop-
ulation stratification, calculated in EIGENSTRAT;28 no
adjustment for population stratification was made in
ALSPAC, as previous analyses have shown that there is no
obvious stratification.
A recent GWAS meta-analysis of adults from the
Genetic Investigation of ANthropometric Traits (GIANT)
consortium has shown that there were no genome-wide
significant gender difference in SNP-BMI associations.29
Therefore, the sexes were combined with the inclusion of a
main sex effect and an interaction between sex and the
spline function for age. This allowed the average BMI tra-
jectory to differ between males and females, but with
genetic effects assumed to be consistent across sexes.
The semi-parametric linear mixed model was fitted for
each individual SNP. Genetic differences in the trajectories
were estimated by including both a main effect for the
imputed dosage and an interaction between the spline
function for age and the imputed dosage for each genetic
variant (i.e. an additive genetic model). We have previously
shown that the type 1 error of the genetic effect over time
in linear mixed effects models may be inflated if the func-
tion involving age terms in the fixed and random effects
differs.30 Therefore, a robust standard error and a corre-
sponding P-value was calculated for each fixed effect
parameter (details in Supplementary material, available as
Supplementary data at IJE online).
To understand the relationship between each SNP and
BMI trajectory, three test statistics were calculated (details
in Supplementary material, available as Supplementary
data at IJE online).
i. Global test (Wald test): to test the association of SNPs
with BMI from 1–17 years of age (denoted as Wald).
This tests the association between an SNP and any
change in BMI.
ii. SNP by age interaction (Wald test): to test the associa-
tion of SNPs with change in BMI trajectory between
1–17 years of age [denoted as Wald(Change)]. This
tests the association between an SNP and any change
in the shape of the BMI curve.
iii. SNP effect at age 8: to test the association of SNPs
with childhood BMI at age 8 years (referred to as ‘BMI
intercept at 8 years’ and denoted as SNP). This repre-
sents the test for a shift up or down of the whole trajec-
tory due to a SNP. The effect is estimated at 8 years as










the age data are mean centred before entering the
semi-parametric linear mixed model.
All analyses were conducted in R [version 3.0.2 (2013-
09-25)]31 using the nlme package. SNPs were excluded if
their MAF was <5% or imputation quality (R2 from
MACH) was <0.3.
Meta-analysis
The meta-analysis for the SNP effect at age 8 years was con-
ducted in Metal32 [http://www.sph.umich.edu/csg/abecasis/
metal/], using inverse variance weighting. The analysis in Metal
included an adjustment for genomic control in both cohorts,
and a test of heterogeneity of the effect sizes was carried out.
Stouffer’s method for combining P-values was used for
the global Wald test and the Wald test for the SNP by age
interaction.33 Genomic inflation k was estimated by divid-
ing the chi-square statistics, with 7 degrees of freedom for
the global Wald test and 6 degrees of freedom for the SNP





ALSPAC and Raine were adjusted for the estimated k val-
ues and weighted by the square root of the respective sam-
ples sizes in the meta-analysis.
Follow-up
The Northern Finland Birth Cohort of 1966 (NFBC1966)
was used to replicate regions that reached genome-wide sig-
nificance (P< 5 108) on any one of the three tests con-
ducted. We investigated the SNP with the lowest P-value in
each region and any potentially functional SNPs that were
in high linkage disequilibrium (LD) with that SNP; LD was
determined from SNAP35 [http://www.broadinstitute.org/
mpg/snap/ldsearchpw.php], and functionality from
snpinfo36 [http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.
htm]. NFBC1966 is a prospective birth cohort from the
region covering the Provinces of Lapland and Oulu,
Finland37 [http://kelo.oulu.fi/NFBC/] (specific methods in
Supplementary material, available as Supplementary data at
IJE online). A subset of 3918 individuals with growth data
(48 530 observations) was included in this study, using the
same criteria as in the discovery cohorts. The study was
approved by ethics committees in Oulu (Finland) and
Oxford (UK) universities in accordance with the
Declaration of Helsinki.
Characterization of significant loci
For loci reaching genome-wide significance, we plotted the
trajectory for each of the genotypes and estimated the ear-
liest age at which the effect of the SNP could be detected.
For novel SNPs, we also investigated their association with
height and weight trajectories using a spline model similar
to that used for BMI (see ref. 11 for description of methods
used). These additional analyses were conducted in the
ALSPAC study only, being the largest discovery cohort.
Results
Each cohort has a similar proportion of males and females;
NFBC1966 has a lower average weight, and consequently
BMI, than the two discovery cohorts from approximately
6 years of age, whereas their average height is similar
(Table 1, and Supplementary Figure 1 available as
Supplementary data at IJE online). The meta-analysis of
approximately 2.2 million SNPs indicated that the lowest
observed P-values for each of the three test statistics devi-
ated from the expected null distribution (Supplementary
Figure 2, available as Supplementary data at IJE online),
whereas any systematic inflation of the test statistics was
negligible (kSNP¼1.03, kWald¼ 1.00, kWald(Change)¼ 1.00).
There was little heterogeneity between the discovery
cohorts (Supplementary Figure 3, available as
Supplementary data at IJE online).
Five regions reached genome-wide significance at
5 108 (Table 2, and Supplementary Table 1 available as
Supplementary data at IJE online); three of these loci have
previously been identified through GWAS of adult BMI
(FTO,38 MC4R39 and ADCY3 8) and one locus has previ-
ously been shown to be associated with paediatric obesity
(OLFM4.18). Manhattan plots for each of the three tests
are in Supplementary Figures 4–6, (available as
Supplementary data at IJE online).
A novel genome-wide significant locus was found
downstream from FAM120AOS, which has not previ-
ously been reported to be associated with any adiposity-
related traits. The most statistically significant SNP,
rs944990, was associated with BMI intercept at 8 years
(T allele: bSNP¼ 0.012, PSNP¼ 1.52 108), and showed
modest evidence of association with change in BMI
(PWald(Change)¼ 0.006; Supplementary Figure 9, available
as Supplementary data at IJE online). A consistent direc-
tion of effect was seen in NFBC1966 for rs944990; how-
ever, P> 0.05 for all three tests (Table 2). Figure 1 shows
the BMI trajectories in the ALSPAC cohort from 1 to 17
years of age in males and females for individuals who
have zero, one or two BMI decreasing alleles (major
allele) at the rs944990 locus. A male homozygous for the
T allele would have an average BMI of 18.16 kg/m2 at 1
year of age, which would increase to an average of 21.88
kg/m2 by age 16. In contrast, a male homozygous for the
C allele would on average have a BMI of 18.12 kg/m2 at
1 year of age and by age 16 it would be 21.48 kg/m2.










Table 1. Characteristics of individuals in the cohorts involved in the discovery meta-analysis and replication
Sex
(% male)
Age stratum Discovery cohorts Replication cohort
ALSPAC (N¼7,916; n¼69,297) Raine (N¼1,461; n¼8,670) NFBC1966 (N¼3,918; n¼48,530)
51.27 51.54 49.74
N Mean (SD) N Mean (SD) Na Mean (SD)
BMI (kg/m2) 1–1.49 2372 17.42 (1.51) 1326 17.11 (1.39) 3304 17.66 (1.57)
1.5–2.49 5490 16.82 (1.49) 389 16.00 (1.25) 2769 16.81 (1.43)
2.5–3.49 1679 16.48 (1.40) 957 16.14 (1.24) 2252 16.13 (1.29)
3.5–4.49 5949 16.25 (1.39) 20 15.92 (1.41) 2194 15.76 (1.32)
4.5–5.49 1602 16.02 (1.70) 3 15.94 (1.43) 1967 15.47 (1.31)
5.5–6.49 3322 15.71 (1.87) 1273 15.85 (1.70) 1870 15.44 (1.54)
6.5–7.49 2728 16.10 (1.98) 43 16.64 (2.85) 3040 15.56 (1.61)
7.5–8.49 3588 16.30 (2.01) 1045 16.89 (2.52) 2629 15.89 (1.76)
8.5–9.49 4376 17.15 (2.41) 205 16.95 (2.57) 1965 16.32 (2.00)
9.5–10.49 5516 17.67 (2.81) 304 18.95 (3.43) 2056 16.88 (2.24)
10.5–11.49 4710 18.25 (3.10) 933 18.66 (3.41) 2619 17.32 (2.42)
11.5–12.49 5116 19.04 (3.35) 4 16.78 (2.65) 2911 17.80 (2.53)
12.5–13.49 5268 19.64 (3.35) 9 21.11 (3.76) 2175 18.58 (2.67)
13.5–14.49 4603 20.30 (3.44) 1201 21.46 (4.17) 2383 19.25 (2.71)
14.5–15.49 2342 21.28 (3.48) 24 21.66 (4.23) 2387 19.77 (2.66)
15.5–16.49 1659 21.39 (3.51) 2 20.14 (3.26) 1191 20.47 (2.88)
16.5þ 91 22.46 (3.39) 931 23.02 (4.37) 970 20.83 (2.66)
Weight (kg) 1–1.49 2372 10.56 (1.31) 1326 10.33 (1.22) 3304 10.52 (1.25)
1.5–2.49 5490 12.01 (1.49) 389 12.98 (1.49) 2769 12.29 (1.46)
2.5–3.49 1679 14.72 (1.89) 957 15.03 (1.81) 2252 14.34 (1.69)
3.5–4.49 5949 16.51 (2.03) 20 15.34 (1.94) 2194 16.27 (2.01)
4.5–5.49 1602 19.42 (2.83) 3 21.97 (1.90) 1967 18.17 (2.34)
5.5–6.49 3322 21.32 (3.37) 1273 21.45 (3.27) 1870 20.39 (3.01)
6.5–7.49 2728 24.98 (4.29) 43 26.00 (5.89) 3040 22.62 (3.46)
7.5–8.49 3588 26.42 (4.68) 1045 28.26 (5.62) 2629 25.04 (4.10)
8.5–9.49 4376 30.33 (5.79) 205 29.75 (5.85) 1965 28.37 (4.88)
9.5–10.49 5516 34.71 (7.30) 304 39.24 (9.06) 2056 31.88 (5.90)
10.5–11.49 4710 38.26 (8.46) 933 39.07 (9.07) 2619 35.32 (6.77)
11.5–12.49 5116 43.60 (9.91) 4 35.85 (6.32) 2911 39.05 (7.78)
12.5–13.49 5268 49.41 (10.58) 9 55.34 (11.15) 2175 44.82 (8.88)
13.5–14.49 4603 54.43 (11.11) 1201 58.47 (13.17) 2383 49.77 (9.14)
14.5–15.49 2342 61.05 (11.85) 24 61.06 (12.74) 2387 53.71 (9.22)
15.5–16.49 1659 61.75 (11.64) 2 57.63 (13.40) 1191 58.02 (9.80)
16.5þ 91 64.64 (11.74) 931 68.79 (14.62) 970 59.94 (9.35)
Height (m) 1–1.49 2372 0.78 (0.04) 1326 0.78 (0.03) 3304 0.77 (0.03)
1.5–2.49 5490 0.84 (0.04) 389 0.90 (0.04) 2769 0.85 (0.04)
2.5–3.49 1679 0.94 (0.04) 957 0.96 (0.04) 2252 0.94 (0.04)
3.5–4.49 5949 1.01 (0.04) 20 0.98 (0.04) 2194 1.02 (0.04)
4.5–5.49 1602 1.10 (0.05) 3 1.18 (0.08) 1967 1.08 (0.05)
5.5–6.49 3322 1.16 (0.06) 1273 1.16 (0.05) 1870 1.15 (0.05)
6.5–7.49 2728 1.24 (0.06) 43 1.25 (0.06) 3040 1.20 (0.05)
7.5–8.49 3588 1.27 (0.06) 1045 1.29 (0.06) 2629 1.25 (0.06)
8.5–9.49 4376 1.33 (0.06) 205 1.32 (0.05) 1965 1.32 (0.06)
9.5–10.49 5516 1.40 (0.06) 304 1.43 (0.06) 2056 1.37 (0.06)
10.5–11.49 4710 1.44 (0.07) 933 1.44 (0.07) 2619 1.42 (0.07)
11.5–12.49 5116 1.51 (0.07) 4 1.46 (0.05) 2911 1.48 (0.07)
12.5–13.49 5268 1.58 (0.08) 9 1.62 (0.06) 2175 1.55 (0.08)
13.5–14.49 4603 1.63 (0.08) 1201 1.65 (0.08) 2383 1.60 (0.08)
14.5–15.49 2342 1.69 (0.08) 24 1.68 (0.06) 2387 1.65 (0.08)
15.5–16.49 1659 1.70 (0.08) 2 1.69 (0.06) 1191 1.68 (0.08)
16.5þ 91 1.69 (0.08) 931 1.73 (0.10) 970 1.70 (0.08)
aDue to the data structure in NFBC1966, some individuals had multiple measures within a 1-year period. This column is the number of unique individuals with
measures in the age bracket.




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In ALSPAC, the effect is detectable from 2 years of age
(Figure 2). Consistent results were observed after includ-
ing additional fixed effects in the model to account for
change in height (Supplementary Table 2, available as
Supplementary data at IJE online). rs944990 showed a
stronger association with weight than height
(Supplementary Table 2) and had the strongest influence
on both weight and height over the pre-pubertal years (7–
10 years; Figures 3 and 4). We investigated the associa-
tion between energy intake and rs944990 from 3 to 14
years of age in the ALSPAC cohort (Supplementary
Table 3, available as Supplementary data at IJE online).
Assuming an additive effect of the SNP, there was a mar-
ginal association at 39 months of age (b¼ 14.28 kCal per
T allele, P< 0.001) and only a slight increase in energy
intake was observed around the peak of the BMI associa-
tion (10 years of age; b¼ 12.80 kCal per T allele,
P¼ 0.03).
The most statistically significant SNP at this novel
FAM120AOS locus in our meta-analysis, rs944990, is in
LD (r2¼ 0.72, D’¼ 0.9635) with a non-synonymous var-
iant that may disrupt splicing activity36, rs10821128. In
the meta-analysis, the C allele of rs10821128 was associ-
ated with an increase in BMI intercept at age 8 years
(bSNP¼ 0.011, PSNP¼ 5.29 108) and showed weak evi-
dence for an increased change in BMI
(PWald¼1.14 104; PWald(Change)¼ 0.014). Given the
potential functionality of this SNP, we analysed
rs10821128 in the NFBC1966 cohort. Consistent with the
results from the meta-analysis, the C allele at rs10821128
was associated with BMI intercept at 8 years of age in
NFBC1966 (bSNP¼0.005, PSNP¼0.041) and the global
Wald test (PWald¼0.041), but not with change in BMI
(PWald(Change)¼ 0.139). Neither this SNP nor rs944990 was
associated with mean BMI (rs944990: P¼ 0.887;
rs10821128: P¼ 0.931) in the GIANT consortium meta-
analysis8 but showed weak evidence of association with
phenotypic variability of BMI40 (rs944990: P¼ 0.063;
rs10821128: P¼ 0.092). We used publicly available results
from GWAS in various consortia to investigate whether
rs944990 or rs10821128 was associated with any other
growth-related endpoint (including BMI, height, waist to
hip ratio, obesity, glucose, insulin, homeostatic model
assessment–insulin resistance (HOMA-IR) and type 2 dia-
betes in adults, age of menarche, pubertal growth and obe-
sity in children and birthweight, birth length and head
circumference at birth). Both rs944990 (P¼ 4.0 104)
and rs10821128 (P¼5.9x104) were associated with age
of menarche, and rs10821128 was marginally associated
with total pubertal growth (P¼0.044), consistent with the
observation that rs944990 influences pre-pubertal weight
and height growth (Figures 3 and 4). Supplementary
Table 4 (available as Supplementary data at IJE online)
presents the association results for other endpoints.
SNPs in FTO (Supplementary Figures 12 and 13, avail-
able as Supplementary data at IJE online) and MC4R
(Supplementary Figures 14 and 15, available as
Supplementary data at IJE online) reached genome-wide sig-
nificance for all three tests, indicating that these loci influence
both BMI intercept at 8 years and change in BMI trajectory
Figure 1. Population average trajectories for females (A) and males (B) from the ALSPAC cohort with 0, 1 or 2 copies of the C allele at the
FAM120AOS, rs944990, locus.










over childhood (FTO rs1558902: bSNP¼ 0.013, PSNP¼
1.541010; PWald¼ 1.48 1021; PWald(Change)¼4.99
1022; MC4R rs571312: bSNP¼0.013, PSNP¼4.94 108;
PWald¼ 1.27 109; PWald(Change)¼2.81 109). The A
allele at rs1558902 in FTO was associated with a decrease in
BMI until 2 years of age, but an increase in BMI from 6 years
of age (Figure 2 and Supplementary Figure 13).
The OLFM4 rs12429545 SNP reached genome-wide sig-
nificance for the SNP effect at age 8 (bSNP¼0.016, PSNP¼
1.90 108) and global Wald tests (PWald¼ 1.13 108)
and showed weak evidence for association with change in
BMI over time (Supplementary Figures 10 and 11, available
as Supplementary data at IJE online).
A missense variant located in ADCY3 reached
genome-wide significance for the SNP effect at age 8
(rs11676272: bSNP¼0.011, PSNP¼ 8.94 109) and
global Wald tests (PWald¼ 1.15109) but not for
the SNP by age interaction terms (PWald(Change)¼ 0.199;
Table 2).
To investigate whether known adult BMI-associated
loci influenced BMI trajectory through childhood and
adolescence, we investigated the relationship between the
33 top adult BMI-associated SNPs and the SNP effect at
age 8 in our meta-analysis. One SNP from the adult BMI
GWAS, rs11847697, was not available in our study as it
had a minor allele frequency less than 5%. We observed
15 loci with directionally consistent associations at nomi-
nal significance (P< 0.05), 12 of which reached P< 0.01.
Figure 5 indicates that the majority of the loci show the
same direction of effect for both the SNP effect at age 8
and the adult BMI meta-analyses. Results from the meta-
analysis of the three tests for the 33 adult BMI-associated
SNPs are presented in Supplementary Figure 16 and
Supplementary Table 5 (available as Supplementary data
at IJE online). We also looked up the HOXB5 and
OLFM4 SNPs, previously associated with childhood
obesity.18 The obesity risk T allele at rs9299 in HOXB5
increased BMI intercept at 8 years (bSNP¼ 0.004,
Figure 2. Associations from the ALSPAC cohort between the genome-wide significant SNPs and BMI from age one to 16 years. Error bars represent
the regression coefficient of BMI on the natural log scale and 95% confidence intervals derived from the longitudinal additive genetic models. The
SNPs are aligned to the minor allele.










PSNP¼ 0.068), but was not associated with change in BMI
over time (PWald¼ 0.591; PWald(Change)¼ 0.728). The obe-
sity risk A allele at rs9568856 near OLFM4 was associ-
ated with increased BMI intercept at 8 years
(bSNP¼ 0.014, PSNP¼ 1.68 106) and increased change
in BMI (PWald¼ 3.24 106; PWald(Change)¼0.002).
Discussion
Previous studies have shown that some genetic variants for
BMI have varying effects across the life course, suggesting
potential age-specific gene expression.14–17 We conducted
a genome-wide meta-analysis of BMI trajectories from 1 to
17 years of age and identified a novel association with
rs944990, downstream from FAM120AOS on chromo-
some 9. This SNP was associated with BMI intercept at 8
years, an effect that was independent of height. The effect
size for the T allele, 0.20 kg/m2 in ALSPAC, is comparable
to the effect sizes reported for adult BMI-associated SNPs.8
In addition, rs944990 showed a stronger association with
adiposity than skeletal growth and had the greatest influ-
ence on pre-pubertal growth. This association did not rep-
licate in the NFBC1966 cohort; however, a potentially
functional non-synonymous SNP in LD was associated
with BMI intercept in NFBC1966. The lack of convincing
evidence for association in NFBC1966 could be due to the
observed difference in BMI trajectories to the ALSPAC and
Raine cohorts (as seen in Supplementary Figure 1); with
fewer individuals in the right-hand tail of the BMI
distribution, it is more difficult to detect an association.
This difference in trajectories could be due to several
causes, including different genetic profiles or generational
effects.
Little is known about the function of FAM120AOS.
However, there are two genes in the region surrounding
FAM120AOS that have shown evidence to support a role
Figure 3. Associations from the ALSPAC cohort between the genome-wide significant SNPs and weight from age one to 16 years. Error bars repre-
sent the regression coefficient of weight on the natural log scale and 95% confidence intervals derived from the longitudinal additive genetic models.
The SNPs are aligned to the minor allele.










for this region in growth. An SNP in the first of those
genes, NINJ1, has been shown to be associated with severe
obesity in children.41 The second gene, PHF2, has been
shown to influence bone development in newborn mice42
and adipocyte differentiation.43 In addition to these two
plausible candidate genes in the region surrounding
FAM120AOS, we identified that the T allele at rs944990
was associated with increased BMI, increased change in
BMI and earlier age of menarche. The direction of effect in
this study is consistent with the observed phenotypic
correlation,44,45 where girls who reach menarche earlier
tend to have a higher BMI in later life than girls who reach
menarche later. The effect seen by rs944990 is similar to
that reported for the LIN28B locus, whereby it influences
BMI and weight from adolescence to early/mid adulthood,
and is associated with age of menarche.46 Therefore, we
believe this region of chromosome 9 warrants further
investigation.
Four loci previously associated with either adult BMI
(FTO,38 MC4R39 and ADCY38) or childhood obesity
(OLFM418) reached genome-wide significance for BMI
level and/or slope. These loci were detected with a smaller
sample size than the original studies (>20 000 subjects in
ref. 18 and 249 796 subjects in ref. 8), consistent with the
increased statistical power gained through using repeated
measures.47 A small increase in BMI may not necessarily
lead to obesity; however, our results demonstrate for the
first time that the obesity risk allele of the OLFM4
rs9568856 SNP18 is associated with increased BMI at 8
years and increased change in BMI over childhood, rather
than having an effect on obesity only. This SNP, along
with the top SNPs from the FTO and MC4R loci, had an
effect at baseline as well as showing an increasing effect
over childhood. In contrast, the top SNP at ADCY3 was
associated with baseline and its effect over time was rela-
tively constant. These results are consistent with previous
Figure 4. Associations from the ALSPAC cohort between the genome-wide significant SNPs and height from age one to 16 years. Error bars represent
the regression coefficient of height and 95% confidence intervals derived from the longitudinal additive genetic models. The SNPs are aligned to the
minor allele.










studies on adult BMI loci.16,17,39 Furthermore, we detected
a decrease in BMI in infancy for the FTO SNP, rs1558902,
followed by an increase from early childhood: a result
which is consistent with our previous work.16
Approximately half of the known adult BMI SNPs showed
nominal effects on BMI at age 8, suggesting that these
SNPs begin having an effect in childhood. The SNP effect
sizes on BMI at age 8 are larger than the effects on adult
BMI for some SNPs; for example, the RBJ/ADCY3 locus
had an effect size of 0.14 kg/m2 in adults8 and 0.18 kg/m2
at age 8. Those SNPs that did not have an effect on BMI in
childhood may indicate early-onset vs adult-onset SNPs or
may be due to lower power in our study.
There are several limitations to this study. These analy-
ses were much more computationally intensive than the
cross-sectional models commonly used in GWAS.27 For
example, both the ALSPAC and Raine GWAS took
approximately 2 months (approximately 1440 h) to ana-
lyse on high performance clusters, i.e. BlueCrystal Phase 2
cluster: [https://www.acrc.bris.ac.uk/acrc/phase2.htm] and
[http://www.ivec.org/], respectively. This computational
burden has limited the current analyses to genetic data on
the 22 autosomes using HapMap2 imputation, rather than
the more recent 1000 genomes, and to two cohorts with
this capacity. Replication is also challenging because of the
need for detailed repeated measures data from across child-
hood and adolescence. Furthermore, there has been some
criticism over recent years of the use of BMI as a measure
of adiposity throughout childhood because at some ages
BMI remains correlated with height and this correlation
changes with age.48 Stergiakouli et al.17 showed that a dif-
ferent power of height was required at different ages
throughout childhood, ranging from 1.5 at 12 months to
3.1 at 8–12 years. However, their results suggest that
genetic influences on weight/height are similar to those for
BMI adjusted for height. We therefore conducted a sensi-
tivity analysis of our novel SNP by including a fixed effect
for change in height and showed that the association
between rs944990 and BMI remained.
Identifying genetic variants that have age-specific effects
has the potential to shed light on the life-course aetiology
of health and disease as well as potentially providing clues
to gene function. Our results are consistent with the
hypothesis that the genetic determinants of adult suscepti-
bility to obesity act on both BMI intercept at 8 years and
trajectory from childhood, change with age and develop
over the life course. As with adult loci, the genetic variants
associated with BMI in children only explain a small pro-
portion of the estimated heritability of childhood BMI.
Hence, considerable opportunity exists for new insights
into the biology of childhood obesity.
Supplementary Data
Supplementary data are available at IJE online.
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